Omicron Boosters Available From Next Month

"); jQuery("#212 h3").html("

Related News Programmes

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1677282_1_20221126100138.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1677282-20221126.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1677282-20221126.htm', 'DCS.dcsqry', '' ); } } }); }); });

2022-11-26 HKT 09:22

Share this story

facebook

  • Omicron boosters available from next month

Booster shots that protect against both the highly-infectious Omicron variant, and the original Covid strain, will be available to the public from next month.

The government made the announcement after around 770,000 doses of the so-called bivalent shots arrived here on Friday. But the Secretary for the Civil Service, Ingrid Yeung, who is in charge of the Covid vaccination programme, said these BioNTech bivalent jabs would only be available as a fourth dose alternative.

"The bivalent vaccine is only for those who are having their fourth dose," she said. "Those who are having their first to third dose, they will not have this choice of the bivalent vaccine or the one that we have already been using."

Currently, the public can choose between the original BioNTech mRNA vaccine, marketed here as Comirnaty, and the Sinovac deactivated virus jab.

The government recommends two groups receive a fourth dose, namely people over 50 and anyone with a weak immune system. People under 50 can also get a fourth Covid shot on a voluntary basis.

The Government has procured a total of 1.9 million doses of the BioNTech bivalent mRNA vaccine. The remaining doses are expected by the end of the year.

mRNA vaccines are new type of vaccine that trigger the body to produce a protein which leads to an immune response.

RECENT NEWS

Tencent Officially Launches T1 Reasoning Model In Chinas Competitive AI Landscape

Tencent has officially unveiled its T1 reasoning model, marking a significant step forward in the increasingly competit... Read more

Ping An Insurance Achieves A 47.8% Rise In 2024 Net Profit

Ping An Insurance (Group) Company of China, Ltd. (Ping An) announced on 19 March 2025 its financial results for the yea... Read more

HashKey Capital Secures Type 1 Licence From SFC, Grows Crypto Services In HK

On 18 March 2025, HashKey Capital received a Type 1 licence from the Hong Kong Securities and Futures Commission (SFC),... Read more

Ping An P&C And FAW Hongqi Launch Hongqi Intelligent Driving Protection Services

Ping An Property & Casualty Insurance Company of China (Ping An P&C), a subsidiary of Ping An Insurance, has pa... Read more

HKSTP European Innovation Mixer Tour Nurtures Global Ties For Hong Kong

The Hong Kong Science and Technology Parks Corporation (HKSTP), led by CEO Albert Wong, conducted the HKSTP European In... Read more

The Full List Of Fintech Unicorns In Hong Kong (2025)

Hong Kong’s fintech landscape has evolved into a dynamic force in Asia, driven by regulatory innovation, technologica... Read more